From October 1, 2023 to January 1, 2024, the company has repurchased 3,014,355 shares, representing 5.93% for $30.43 million. With this, the company has completed the repurchase of 31,414,836 shares, representing 49.07% for $325 million under the buyback announced on September 19, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.465 USD | -0.26% | +0.53% | -16.19% |
12/04 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
12/04 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.19% | 461M | |
+32.68% | 698B | |
+26.51% | 568B | |
-4.54% | 358B | |
+19.53% | 328B | |
+3.48% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+9.01% | 165B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.